ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

BIMEKIZUMABUM

Active substance (INN) · ATC L04AC21 · 2 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
L040M	ARTRITA PSORIAZICĂ – AGENŢI BIOLOGICI: ADALIMUMABUM1 (ORIGINAL ŞI BIOSIMILAR), CERTOLIZUMABUM1, ETANERCEPTUM1 (ORIGINAL ŞI BIOSIMILAR), GOLIMUMABUM1, INFLIXIMABUM…	In force	medicine of the protocol	C1-G31C	NO
L044L	PSORIAZIS CRONIC SEVER (ÎN PLĂCI) - AGENŢI BIOLOGICI ŞI TERAPII CU MOLECULE MICI CU ACŢIUNE INTRACELULARĂ	In force	mentioned in the text	C1-G31F	YES

History: entries into and exits from protocols

Month	Type	Code	Protocol	Level
April 2026	Medicine added	L040M	ARTRITA PSORIAZICĂ – AGENŢI BIOLOGICI: ADALIMUMABUM1 (ORIGINAL ŞI BIOSIMILAR), CERTOLIZUMABUM1, ETANERCEPTUM**1 (ORIGINAL ŞI BIOSIMILAR)	medicine of the protocol

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
BIMZELX 160 mg	SOL. INJ. IN STILOU INJECTOR PREUMPLUT	160mg/ml	UCB PHARMA S.A. - BELGIA	L04AC21	PR
BIMZELX 320 mg	SOL. INJ. IN STILOU INJECTOR PREUMPLUT	320mg/2ml	UCB PHARMA S.A. - BELGIA	L04AC21	PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.